Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

TP53 mutation screening for patients at risk of myeloid malignancy

25 May 2024

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Acute Myeloid Leukemia Research
Share to Sarcoma Diagnosis and Treatment
Share to Vascular Tumors and Angiosarcomas

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 38796530
DOI: 10.1038/s41375-024-02283-x

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

TP53 mutation screening for patients at risk of myeloid malignancyPMID 38796530Read ↗

TP53 mutations in myeloid neoplasms: implications for accurate laboratory detection, diagnosis, and treatment.Semantic proximity Read ↗

<i>TP53</i>mutation screening for patients at risk of myeloid malignancySemantic proximity Read ↗

Clinical implications of subclonal TP53 mutations in acute myeloid leukemiaSemantic proximity Read ↗

Breaking the guardian of the genome: TP53 dysfunction in myeloid neoplasms.Semantic proximity Read ↗

A clinical guide to TP53 mutations in myeloid neoplasms.Semantic proximity Read ↗

TP53 -Mutated Myeloid Neoplasms: 2024 Update on Diagnosis, Risk-Stratification, and Management.Semantic proximity Read ↗

TP53 mutation in therapy-related myeloid neoplasm defines a distinct molecular subtype.Semantic proximity Read ↗

TP53 mutations in myeloid malignancies are either homozygous or hemizygous due to copy number-neutral loss of heterozygosity or deletion of 17pSemantic proximity Read ↗

TP53 Y220C mutations in patients with myeloid malignancies.Semantic proximity Read ↗

Pathogenic germline TP53 mutations in adult sarcoma patients; implications for treatment and screening – description of an upcoming projectSemantic proximity Read ↗

Recent advances in the understanding of TP53 in haematological malignancies.Semantic proximity Read ↗

TP53 mutation variant allele frequency of ≥10% is associated with poor prognosis in therapy-related myeloid neoplasms.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.